# Fan Yu

Fan Yu of Grand Cayman, E9 appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 22 filing roles across Form D (17), Form 13F (4), Form ADV (1).

## Filings (22)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| 2025-03-31 | Form ADV | [ALLY BRIDGE GROUP (NY) LLC](https://search.stillhousedata.com/firm/291072) | SHAREHOLDER AND DIRECTOR | NEW YORK, NY |
| 2026-02-17 | Form 13F | [Yu Fan](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1668029&type=&dateb=&owner=include&count=40) | Self | CENTRAL, HONG KONG, K3 |
| 2026-02-17 | Form 13F | [Ally Bridge Group (NY) LLC](https://search.stillhousedata.com/firm/291072) | Director | NEW YORK, NY |
| 2026-02-17 | Form 13F | [ABG-WTT Global Life Science Capital Partners GP Ltd](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1832108&type=&dateb=&owner=include&count=40) | Director | CENTRAL, HONG KONG, K3 |
| 2026-02-17 | Form 13F | [ABG Innovation Capital Partners III GP Ltd](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1845297&type=&dateb=&owner=include&count=40) | Director | CENTRAL, HONG KONG, K3 |
| 2011-08-17 | Form D | [Themes Investment Partners II, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1478983&type=&dateb=&owner=include&count=40) | Executive Officer | Hong Kong, K3 |
| 2017-03-22 | Form D | [LoneStar Heart, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1493499&type=&dateb=&owner=include&count=40) | Director | IRVINE, CA |
| 2018-07-16 | Form D | [Atea Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1593899&type=&dateb=&owner=include&count=40) | Director | BOSTON, MA |
| 2015-05-28 | Form D | [Ally Bridge Group Capital Partners II, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1609313&type=&dateb=&owner=include&count=40) | Director | Hong Kong, F4 |
| 2014-12-22 | Form D | [ABG Team L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1628857&type=&dateb=&owner=include&count=40) | Director | Hong Kong, K3 |
| 2021-07-21 | Form D | [Imperative Care, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1668962&type=&dateb=&owner=include&count=40) | Director | CAMPBELL, CA |
| 2018-05-04 | Form D | [Ally Bridge Group Innovation Capital Partners III, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1674513&type=&dateb=&owner=include&count=40) | Director | HONG KONG, F4 |
| 2017-10-04 | Form D | [ABG Innovation Team, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1686922&type=&dateb=&owner=include&count=40) | Director | HONG KONG, F4 |
| 2017-04-03 | Form D | [Ally Bridge Group Flagship Capital Partners, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1702738&type=&dateb=&owner=include&count=40) | Director | HONG KONG, F4 |
| 2025-11-14 | Form D | [Ally Bridge MedAlpha International Fund Ltd](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1722696&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2021-08-11 | Form D | [Sonoma Biotherapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1877861&type=&dateb=&owner=include&count=40) | Director | SOUTH SAN FRANCISCO, CA |
| 2024-09-20 | Form D | [Ally Bridge Group Global Life Science Capital Partners V, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1951727&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2024-09-20 | Form D | [ABG V Team, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2026013&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2024-12-06 | Form D | [ABG-SIV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2047531&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2025-05-09 | Form D | [ABG-SIV IV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2067601&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2026-03-11 | Form D | [ABG-SIV II, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2116445&type=&dateb=&owner=include&count=40) | Director | GRAND CAYMAN, E9 |
| 2026-07-09 | Form D | [ABG-Mainstay L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2144073&type=&dateb=&owner=include&count=40) | Related Person | GRAND CAYMAN, E9 |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.